Loading chat...

IA SF2322

Bill

Official Source

Status

Introduced

2/12/2026

Primary Sponsor

Sarah Trone Garriott

Click for details

Origin

Senate

91st General Assembly

AI Summary

  • Caps out-of-pocket costs for prescription insulin at $35 maximum per prescription for up to a 31-day supply
  • Applies to rapid-acting, short-acting, intermediate-acting, and long-acting insulin types when prescribed as medically necessary
  • Covers individual and group health insurance policies, hospital/medical service contracts, HMO contracts, and public employee plans
  • Takes effect for policies delivered, issued, continued, or renewed on or after January 1, 2027
  • Does not apply to accident-only, dental, vision, Medicare supplement, long-term care, disability income, or workers' compensation insurance

Legislative Description

A bill for an act relating to insurance coverage for prescription insulin drugs.

Last Action

Subcommittee: Warme, Dickey, and Drey. S.J. 331.

2/19/2026

Committee Referrals

Commerce2/12/2026

Full Bill Text

No bill text available